Here are relevant reports on : insulin-market
-
Insulin Pump Market by Product (Disposable Insulin Pump, Smart Pump, Traditional Insulin Pump), Accessories (Infusion Sets, Insulin Reservoirs/Cartridges, Infusion Set Insertion Devices) – Global Forecast to 2020
Insulin pumps are the devices used to administer insulin in the body to control the diabetes. The global insulin pumps and accessories market is broadly segmented into insulin pumps, infusion sets, insulin reservoirs/cartridges, infusion set insertion devices, and others. The pivotal factors driving the growth of this market are increasing prevalence of diabetes, development of various types of insulin, and growing awareness towards diabetes and insulin delivering devices. In addition, development of artificial pancreas and home infusion therapy is further promoting the growth of this market to a certain extent. Moreover, professional and consumer information programs provided by insulin infusion pump manufacturers are encouraging adoption of insulin delivering devices and ultimately driving the growth of this market. However, various concerns associated with insulin delivering devices such as skin infections and high cost of the insulin analogs and pumps are hampering the growth of this market. In addition, lack of skilled professional for appropriate handling of insulin pump further restrains the growth of this market to a certain extent. Moreover, currently, research on aerosolized insulin for inhalation, oral insulin, and insulin-producing stem cell implantation is going on and positive result will lead to hamper the growth of this market. Geographically, North America is the largest market for global insulin pump and accessories market, with the U.S. contributing a major share, followed by Europe, Asia-Pacific, and the Rest of the World. North America and Europe will continue to dominate the market during the forecast period owing to the growing number of diabetic patients and technological advancement in insulin pump. However, a majority of the growth in the insulin pump and accessories market is expected to be from emerging markets in the Asia-Pacific, owing to the growing number of diabetes patients and increasing awareness towards glycemic control and advance insulin delivery devices in these regions.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Insulin Delivery System Market - 2019 By Types, Application & Geography
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Insulin Delivery Device Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others), Disease Type (Type 1 Diabetes, Type 2 Diabetes) - Global Forecast to 2030
The global insulin delivery devices market, valued at US$32.6 billion in 2024, stood at US$35.3 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2030, culminating in a forecasted valuation of US$ 52.7 billion by the end of the period. The insulin delivery devices market is experiencing steady growth, primarily due to the increasing number of individuals diagnosed with diabetes. The rising prevalence of type 1 diabetes, in particular, is driving the demand for insulin delivery devices, as patients with this condition rely on insulin to manage their blood glucose levels.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Human Insulin Market By Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Global Forecast to 2020
The global human insulin market size is projected to grow at a CAGR of 8.1%. Market growth can be attributed to factors such as growing diabetes patient population, increasing population exposure to key risk factors leading to diabetes, rising market demand for human insulin analogs, technological advancements in the field of human insulin delivery devices, and favorable medical reimbursements. However, stringent regulatory requirements for product approval are restraining the growth of this market.
- Published: December 2015
- Price: $ 4950
- TOC Available:
-
Europe Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Self/Home Healthcare) - Forecast to 2031
The Europe digital diabetes management market, valued at USD 6.89 billion in 2025, stood at USD 7.78 billion in 2026 and is projected to advance at a resilient CAGR of 10.0% from 2026 to 2031, culminating in a forecasted valuation of USD12.53 billion by the end of the period. Europe is a significant enabler of digital diabetes management. These devices generate continuous, real-time data that can be integrated into digital platforms for monitoring, alerts, and personalized insights.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2035
The global biosimilars market, valued at US$32.75 billion in 2024, stood at US$35.04 billion in 2025 and is projected to advance at a resilient CAGR of 7.5% from 2025 to 2035, culminating in a forecasted valuation of US$72.29 billion by the end of the period. This growth is driven by several key factors, including a rising number of regulatory approvals and product launches, the patent expiries of major biologics, and the increasing prevalence of chronic diseases that require effective and affordable treatment options.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Endocrine Testing Market by Type (Thyroid, Insulin, HCG, Prolactin, Progesterone, LH, FSH), Technology (Immunoassay, Tandem Mass Spectroscopy, Clinical Chemistry), End User (Hospitals, Clinical Laboratories) - Global Forecast to 2027
The global Endocrine Testing Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the increasing prevalence of the endocrine disorders such as thyroid imbalance, diabetes, Polycystic Ovary Syndrome, etc. Also, the increasing government funding and rising awareness for the endocrine hormone tests for the diagnosis and management of the endocrine disorder have also fueled the growth of the market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Proteins & Protein Crystals Market by Product Type (Enzyme, Monoclonal Antibodies, Insulin, Hormones); Structural (Membrane, Matrix), Specialty (Nutrition, Analytics, Cosmetics); Application (Healthcare, Environmental); End User (Pharma, Biotech, CROs) - Global Forecast to 2030
The global proteins & protein crystals market, valued at US$557.00 billion in 2024, stood at US$609.51 billion in 2025 and is projected to advance at a resilient CAGR of 9.5% from 2025 to 2030, culminating in a forecasted valuation of US$960.37 billion by the end of the period. The growth of the proteins & protein crystals market is fueled by rising demand for biologics and protein-based medicines, continuous technological improvements in crystallization techniques, and increased research spending in biopharmaceuticals and drug discovery.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Latin America Infusion Pump Market by Product (Accessories & Consumables, Devices (Volumetric, Insulin, Syringe, Ambulatory, PCA)), Application (Chemotherapy, Diabetes, Analgesia, Pediatrics, Hematology), End User (Hospitals) - Global Forecast to 2030
The global Latin America infusion pumps market, valued at US$707.6 million in 2024, stood at US$743.7 million in 2025 and is projected to advance at a resilient CAGR of 6.2% from 2025 to 2030, culminating in a forecasted valuation of US$1,004.9 million by the end of the period. The Latin America infusion pumps market is growing rapidly due to increasing healthcare awareness and improved access to advanced medical technologies across the region.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Safety Syringes Market by Technology (Retractable, Non-Rectractable, Sliding Needle, Sheathing Tube, Hinged Needle), Threapy (Insulin, Tuberculosis), Type (Attached Needle, Detachable Needles) - Analysis & Global Forecast to 2019
Safety syringes are equipped with an inbuilt safety mechanism and needles that detachable or permanently attached. The safety mechanism is designed to protect healthcare workers from accidental needlestick injuries. The global safety syringes market is expected to show considerable growth during the forecast period. This is attributed to rising incidence of needlestick injuries, government initiative to incorporate the use of safety syringes in the legislation, favorable reimbursement policies, and enhanced safety mechanisms for syringes. Several countries have introduced regulations to ensure the compulsory use of safety syringes with an aim of decreasing to needle stick injuries and prevent needle re-use. These regulations are expected to cause more common usage of safety syringes as compared to conventional syringes. However factors such as alternative drug delivery methods and high cost are limiting the growth of this market. In addition, the lack of awareness regarding healthcare and safety issues in emerging economies has restricted the market growth in the region.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
